Gene expression of Pnpla3 has also been reported to be decreased in rat primary activated hepatic stellate cells [18], whereas in human primary hepatic stellate cells and MASH patients in the transition from mild to severe fibrosis, the opposite was observed [75, 76]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatohepatitis.